Top

Published in:

01-01-2015 | Commentary

Caring for terminal patients in haematology: the urgent need of a new research agenda

Authors: Pasquale Niscola, Andrea Tendas, Marco Giovannini, Laura Scaramucci, Alessio Perrotti, Paolo de Fabritiis, Debra A Howell

Published in: Supportive Care in Cancer | Issue 1/2015

Abstract

Although major therapeutic advances have led to improved survival for many hematologic malignancies in recent years, survival remains poor for some disease subtypes and a substantial proportion of patients are ultimately destined to die from their disease and/or related complications. Despite this, there is evidence that patients are not always referred to palliative/home care services as often as those with other cancers, although this situation may be improving in some areas. More research is needed, however, to explore reasons for this and identify whether patients may consequently have unmet needs that impact on their quality of life at this time.

Joske D, McGrath P (2007) Palliative care in haematology. Int Med J 37:589–90. doi:10.1111/j.1445-5994.2007.01438.x CrossRef

Niscola P, Tendas A, Scaramucci L et al (2013) End of life care in hematology: still a challenging concern. Ann Palliat Med 3:7–11

Howell DA, Roman E, Cox H et al (2010) Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy. BMC Palliat Care 9:9PubMedCentralPubMedCrossRef

Smith A, Roman E, Howell D et al (2010) The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol 148:739–53PubMedCentralPubMedCrossRef

Howell DA, Wang H-I, Roman E et al (2014) Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma. BMJ Support Palliat Care. doi:10.1136/bmjspcare-2013-000578, bmjspcare–2013–000578PubMed

Niscola P, Cartoni C, Romani C et al (2007) Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey. Ann Hematol 86:671–6. doi:10.1007/s00277-007-0296-4 PubMedCrossRef

McGrath P (1999) Palliative care for patients with hematological malignancies—if not, why not? J Palliat Care 15:24–30PubMed

Howell DA, Wang H-I, Smith AG et al (2013) Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death. BMC Palliat Care 12:42PubMedCentralPubMedCrossRef

Efficace F, Cartoni C, Niscola P et al (2012) Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter? Eur J Haematol 89:410–6. doi:10.1111/ejh.12004 PubMedCrossRef

10.

Kripp M, Willer A, Schmidt C et al (2014) Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors. Ann Hematol 93:317–25. doi:10.1007/s00277-013-1861-7 PubMedCrossRef

11.

Cheng BHW, Sham MMK, Chan KY, et al. (2013) Intensive palliative care for patients with hematological cancer dying in hospice. Analysis of the level of medical care in the final week of life. Am J Hosp Palliat Med; 1049909113512412 doi:10.1177/1049909113512412

12.

Tang ST, Wu S-C, Hung Y-N et al (2009) Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006. J Clin Oncol Off J Am Soc Clin Oncol 27:4613–8. doi:10.1200/JCO.2008.20.5096 CrossRef

13.

McGrath P, Leahy M (2009) Catastrophic bleeds during end-of-life care in haematology: controversies from Australian research. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 17:527–37. doi:10.1007/s00520-008-0506-1

14.

Manitta V, Zordan R, Cole-Sinclair M et al (2011) The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manag 42:432–42. doi:10.1016/j.jpainsymman.2010.12.008 CrossRef

15.

Fadul NA, El Osta B, Dalal S et al (2008) Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med 11:422–7PubMedCrossRef

16.

Tendas A, Niscola P, Ales M et al (2009) Disability and physical rehabilitation in patients with advanced hematological malignancies followed in a home care program. Support Care Cancer 17:1559–60. doi:10.1007/s00520-009-0732-1 PubMedCrossRef

17.

Howell DA, Shellens R, Roman E et al (2011) Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data. Palliat Med 25:630–41PubMedCrossRef

18.

Corbett CL, Johnstone M, Trauer JM et al (2013) Palliative care and hematological malignancies: increased referrals at a comprehensive cancer centre. J Palliat Med 16:537–41. doi:10.1089/jpm.2012.0377 PubMedCrossRef

19.

Niscola P, de Fabritiis P, Cartoni C et al (2006) Home care management of patients affected by hematologic malignancies: a review. Haematologica 91:1523–9PubMed

20.

Niscola P, Tendas A, Giovannini M et al (2012) Transfusions at home in patients with myelodysplastic syndromes. Leuk Res 36:684–8. doi:10.1016/j.leukres.2012.01.010 PubMedCrossRef

Title: Caring for terminal patients in haematology: the urgent need of a new research agenda
Authors: Pasquale Niscola
Andrea Tendas
Marco Giovannini
Laura Scaramucci
Alessio Perrotti
Paolo de Fabritiis
Debra A Howell
Publication date: 01-01-2015
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 1/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-014-2489-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

Clinical implications of malnutrition in childhood cancer patients—infections and mortality

Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2,388 health care providers

Comparison of a novel, simple nutrition screening tool for adult oncology inpatients and the Malnutrition Screening Tool (MST) against the Patient-Generated Subjective Global Assessment (PG-SGA)

Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study

Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom

Physicians’ attitude toward recurrent hypercalcemia in terminally ill cancer patients

Keynote webinar | Spotlight on antibody–drug conjugates in cancer